Dr. Klufas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
840 Walnut St
10th Floor
Philadelphia, PA 19107Phone+1 800-331-6634Fax+1 610-383-0248- Is this information wrong?
Summary
- Dr. Michael Klufas is an ophthalmologist in Philadelphia, PA and is affiliated with Wills Eye Hospital and Nemours Children's Hospital. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 7 years. He specializes in retinal disease and is experienced in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retina vein occlusion, retinopathy of prematurity, retina surgery, ophthalmology, vitreoretinal disease, and choroid neoplasms.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Surgical Retina and Vitreous, 2014 - 2016
- New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 2011 - 2014
- Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2010 - 2011
- Weill Cornell MedicineClass of 2010
Certifications & Licensure
- DE State Medical License 2016 - 2025
- NJ State Medical License 2016 - 2025
- PA State Medical License 2015 - 2024
- CA State Medical License 2014 - 2020
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.Momenaei, B., Wakabayashi, T., Vemula, S., Durrani, A., Pandit, S., Hsu, J., Ho, A., Spirn, M., Klufas, M., Garg, S., Vander, J., Regillo, C., Chiang, A., Kuriyan, A.,...> ;The British Journal of Ophthalmology. 2024 Feb 12
- 1 citationsEnhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema.Nikhil K Mandava, Ajay E Kuriyan, Allen C Ho, Jason Hsu, Carl D Regillo, Michael A Klufas> ;Current Opinion in Ophthalmology. 2024 May 1
- Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal Injections.Rachel N Israilevich, Hana Mansour, Samir N Patel, Sunir J Garg, Michael A Klufas, Yoshihiro Yonekawa, Carl D Regillo, Jason Hsu> ;Ophthalmology. 2024 Jan 3
- Join now to see all
Press Mentions
- A UNIQUE EXPLORATION OF OCT IMAGING: Optical Coherence Tomography – Its Uses and Benefits for Each Part of the EyeJanuary 21st, 2020
Hospital Affiliations
- Wills Eye HospitalPhiladelphia, Pennsylvania
- Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: